The study also reviews the great potential of mRNA vaccines to treat influenza, RSV, cancer, and autoimmune diseases.

Adults who received the updated mRNA-1273 COVID-19 vaccine experienced a lower risk for hospitalization compared with NVX-CoV2705 recipients.

A comprehensive new review published in The Lancet affirms that currently approved mRNA vaccines are safe and highly ...

Messenger RNA (mRNA) vaccines are one of the biggest medical breakthroughs of recent years. It was first introduced during ...

No vaccine-related serious adverse events (SAEs) or sustained Grade 3 or higher adverse events related to the vaccine reported SOUTH SAN FRANCISCO, Calif., July 06, 2026 (GLOBE NEWSWIRE) -- Vaxart, ...

VRBPAC endorsed mRNA-1010 for adults 50-64 and ≥65 years, unanimously concluding benefits outweighed risks, supporting a late-stage regulatory path toward potential first mRNA seasonal influenza ...

Online content falsely claiming vaccines can be distributed through the food supply has circulated for years and a new series ...

A sweeping global review led by researchers at the University of British Columbia has found that mRNA vaccines—now ...

A massive, global review of mRNA vaccines has shown that they are very effective and safe. Reporting in The Lancet, ...

MRNA vaccines are effective and safer than getting COVID-19, according to a large-scale review published in The Lancet, which ...

"After billions of doses, we now have an extraordinary amount of scientific evidence." The post Huge Survey Finds the Truth ...

Among healthy adults receiving the JN.1- or KP.2-adapted mRNA seasonal COVID-19 vaccine, neutralizing antibody responses were similar.